Cannabis Kiwi medical cannabis firm secures largest distribution deal to date NZX-listed Rua Bioscience will get the equivalent of US$5.8M over the next two years Rowan DunneJuly 17, 2026
Cannabis Tilray’s medical cannabis division enters Panama with CBD shipments The nation's legal sector is small and growing slowly Rowan DunneJuly 13, 2026
Cannabis Glass House joins Trulieve on New York Stock Exchange after rescheduling momentum Shares started trading on the major equity market Jun. 30 Rowan DunneJuly 2, 2026
Cannabis Tilray strengthens medical cannabis reach with HelloMD acquisition Financial terms of the deal were not disclosed Rowan DunneJune 30, 2026
Cannabis Trulieve set to become first NYSE-listed cannabis company CEO Kim Rivers was instrumental in getting Trump to issue an executive order for rescheduling Rowan DunneJune 8, 2026
Cannabis SNDL’s plan to acquire 27 more dispensaries from 1CM falls through The regulatory process has been dragging on for far too long Rowan DunneMay 29, 2026
Cannabis Curaleaf scoops trio of accolades at Business of Cannabis Awards This is the 3rd year that the media company's event has been held Rowan DunneMay 28, 2026
Cannabis Department of Justice demands US$8.3M from TerrAscend in legal tax dispute The DOJ says that the MSO received an 'erroneous' refund and wants interest too Rowan DunneMay 22, 2026
Cannabis Cannabis telehealth operator Veri Medtech aims for Nasdaq uplisting Veri will be offering 3.75 million common shares at US$4 apiece Rowan DunneMay 11, 2026
Cannabis Fugazi short report sends Akanda tumbling after cannabis rescheduling rally The firm described AKAN as a 'half-baked cannabis company where shareholders get smoked' Rowan DunneMay 6, 2026